Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K LittleJohn

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Information Journal|December 11, 1986
Package insert: view of a rural town practitionerJ K LittleJohn
The American Journal of Cardiology|May 11, 1992
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarctionJ Kalbfleisch, U Thadani, J K LittleJohn, et al.
The American Journal of Cardiology|May 1, 1993
Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction. The Wellcome Tissue Plasminogen Activator Study GroupZ G Turi, S Goldberg, J K LittleJohn, et al.
The American Journal of Medicine|April 1, 1992
Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activatorC S Kase, M S Pessin, J A Zivin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Information Journal|December 11, 1986
Package insert: view of a rural town practitionerJ K LittleJohn
The American Journal of Cardiology|May 11, 1992
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarctionJ Kalbfleisch, U Thadani, J K LittleJohn, et al.
The American Journal of Cardiology|May 1, 1993
Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction. The Wellcome Tissue Plasminogen Activator Study GroupZ G Turi, S Goldberg, J K LittleJohn, et al.
The American Journal of Medicine|April 1, 1992
Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activatorC S Kase, M S Pessin, J A Zivin, et al.
Pageof 1